To Check the Comparative Effectiveness of "Wholesome and Unwholesome Diet and Lifestyle counselling" in management of "Rheumatoid Arthritis"

A Comparative Study to Evaluate Effectiveness of "Pathya Counselling"in Management of "Amavata (Rheumatoid Arthritis)"

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017359

Enrollment

Registered

2019-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Pathya Counselling Advised along with Commonly Prescribed Ayurvedic treatment in Amavata: Wholesome and Unwholesome Diet and Lifestyle Counselling advised along with Commonly Prescribed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having the clinical features of Amavata as described in Madhav Nidana Patients fulfilling the 2010 ACR-EULAR criteria for Rheumatoid arthritis Patients who are only on commonly prescribed Ayurvedic treatment of Amavata Patients not following any dietary restrictions from past 6 months Age 21 to 60 years Sex both sexes Patients suffering from disease for less than 3yrs Patients who are ready to give consent for trial Patients with firm home address and contact no which is readily accessible during course of trial

Exclusion criteria

Exclusion criteria: Concomitant any other treatment (DMARDs glucocorticoids etc) other than commonly prescribed Ayurvedic treatment of Amavata Patients with crippling bone deformities Seriously ill and moribund patients Abnormal renal or hepatic functions malignancy hypertension cardiovascular disorder HIV-AIDS etc Patients planning to conceive in near future (during course of trial) Pregnant and lactating mothers Any major psychiatric illness Any other pre-existing illness that will require surgery during course of trial Patients with any other concomitant Arthropathy like Ankylosing Spondylosis Osteomyelitis Gouty Arthritis Neoplasm of spine Fractures etc

Design outcomes

Primary

Measure	Time frame
Reduction in DAS-28 scoreTimepoint: Day1 Day42 Day49	—

Secondary

Measure	Time frame
Attainment of status of Dhatu Samayata and Vikaropsama Reduction in Amavata symptom severity scale Timepoint: Day1 Day7 Day14 Day21 Day28 Day35 Day42 Day49;Reduction in Visual Analogue Scale (VAS) and Erythrocyte Sedimentation Rate (ESR)Timepoint: Day1 Day42 Day49	—

Countries

India

Contacts

Public ContactDr Yogesh Kumar Pandey

Chaudhary Brahm Prakash Ayurved Charak Sansthan

aakankshaarora_55@yahoo.in8860796456

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026